2002Acta Academiae Medicinae CpapfRequires access

Study on the bioavailability of Atenolol tablet

Peng Wen-xin

Open publisher page 0 citations

Abstract

Objective:To establish a method to determine atenolol concentration in plasma by SPE-HPLC,and to study relative bioavailability of atenolol tablet.Methods:The atenolol concentrations in plasma through solid-phase extraction were determined by HPLC method following a single oral dose were given to 12 volunteers.Results:RSD of intra-day and inter-day were less than 10% and recovery rates of plasma coincided for pharmacokinetic study.The pharmacokinetic parameters of experimental tablets and comparative tablets AUC 0~36 ?C max ?T max ?t 1/2 was 5150 35±1172 52ng·h/ml and 5466 50±1277 08ng·h/ml,717 04±189 69ng/ml and 678 63±193 36ng/ml,2 42±0 45h and 2 63±0 54h,7 84±1 25h and 7 73±1 59h.There were no significant different between the two in formulations in the AUC T max ?C max .Conclusion:The SPE-HPLC method to determine atenolol concentration is a good method.The two formulations were bioequivalent,the relative bioavailbility was 94 22%.

About this research paper

What this paper is about

Objective:To establish a method to determine atenolol concentration in plasma by SPE-HPLC,and to study relative bioavailability of atenolol tablet.Methods:The atenolol concentrations in plasma through solid-phase extraction were determined by HPLC method following a single oral dose were given to 12 volunteers.Results:RSD of intra-day and inter-day were less than 10% and recovery rates of plasma coincided for pharmacokinetic study.The pharmacokinetic parameters of experimental tablets and comparative tablets AUC 0~36 ?C max ?T max ?t 1/2 was 5150 35±1172 52ng·h/ml and 5466 50±1277 08ng·h/ml,717 04±189 69ng/ml and 678 63±193 36ng/ml,2 42±0 45h and 2 63±0 54h,7 84±1 25h and 7 73±1 59h.There were no significant different between the two in formulations in the AUC T max ?C max .Conclusion:The SPE-HPLC method to determine atenolol concentration is a good method.The two formulations were bioequivalent,the relative bioavailbility was 94 22%.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To establish a method to determine atenolol concentration in plasma by SPE-HPLC,and to study relative bioavailability of atenolol tablet.Methods:The atenolol concentrations in plasma through solid-phase extraction were determined by HPLC method following a single oral dose were given to 12 volunteers.Results:RSD of intra-day and inter-day were less than 10% and recovery rates of plasma coincided for pharmacokinetic study.The pharmacokinetic parameters of experimental tablets and comparative tablets AUC 0~36 ?C max ?T max ?t 1/2 was 5150 35±1172 52ng·h/ml and 5466 50±1277 08ng·h/ml,717 04±189 69ng/ml and 678 63±193 36ng/ml,2 42±0 45h and 2 63±0 54h,7 84±1 25h and 7 73±1 59h.There were no significant different between the two in formulations in the AUC T max ?C max .Conclusion:The SPE-HPLC method to determine atenolol concentration is a good method.The two formulations were bioequivalent,the relative bioavailbility was 94 22%.

Key concepts: Atenolol, Bioavailability, Bioequivalence, Pharmacokinetics, Chromatography, High-performance liquid chromatography, Chemistry, Plasma concentration

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on the bioavailability of Atenolol tablet — Research Paper | ScholarLens